Inactive Instrument

Other languages Northwest Biotherapeutics, Inc. Other OTC

Equities

NWBO

US66737P6007

Other languages

Unlock all the news: Be the first to know and act before the market!

Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	03-21
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	03-14
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	12-21
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Northwest Biotherapeutics Appoints Linda Liau to its Scientific Advisory Board	23-09-12
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28
Northwest Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt	23-02-27
Northwest Biotherapeutics Sues Citadel Securities, Other Market Market Makers for Alleged Stock Price Manipulation	22-12-01
Northwest Biotherapeutics Reports Positive Top-Line Results from Phase 3 Trial of DCVax®-L for Glioblastoma	22-11-17
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-01
Northwest Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt	22-02-28
Northwest Biotherapeutics Announces Commencement of Cancer Vaccine Production At Its Sawston, UK Facility	22-02-17
Northwest Biotherapeutics Announces MHRA Approval Of License for GMP Manufacturing at Sawston, UK Facility	21-12-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Northwest Biotherapeutics, Inc. Other OTC

Equities

NWBO

US66737P6007

Other languages

Filters